Significant therapeutic effectiveness of durvalumab after chemoradiotherapy for a patient with post‐operative recurrent pulmonary pleomorphic carcinoma

Pulmonary pleomorphic carcinoma (PPC) is a poorly differentiated non‐small cell lung cancer. Because of its rarity, no standard therapy has been established for advanced disease. We herein report on a 62‐year‐old man with recurrent post‐operative PPC, for whom durvalumab after chemoradiotherapy was...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimamura, So, Saiki, Masafumi, Ide, Shuichiro, Masuda, Kazuki, Uchida, Yoshinori, Sogami, Yusuke, Kasai, Kazunari, Inoue, Tomohiro, Ishihara, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112115/
https://www.ncbi.nlm.nih.gov/pubmed/34012549
http://dx.doi.org/10.1002/rcr2.781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112115/
https://www.ncbi.nlm.nih.gov/pubmed/34012549
http://dx.doi.org/10.1002/rcr2.781

Ejemplares similares